Divi’s Laboratories Limited is a Company limited by shares, incorporated and domiciled in India. The company is among the world’s leading Active Pharmaceutical Ingredient (API) manufacturers, specialising in Generic APIs, Custom Synthesis, and Nutraceuticals. As a reliable partner for complex, highly technical, and sustainable chemistry, the company collaborates with global pharmaceutical companies to deliver quality-driven and technically advanced APIs/ intermediates. With state-of-the-art facilities, advanced R&D and cutting-edge technology, it drives continuous innovation. Its collaborative approach, operational excellence and backward integration have fostered long-standing customer relationships.
The company established a strong global presence with a well-diversified revenue base across key pharmaceutical markets. Supported by a robust manufacturing and R&D infrastructure, along with strategically positioned international offices, it enhances operational agility and customer engagement, reinforcing its commitment to excellence on a global scale. The company operates across the entire pharmaceutical value chain, from research & development to commercial production, ensuring the highest quality and compliance standards.
Business area of the company
The company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generics, the Company, through its custom synthesis, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. The Company has two wholly owned subsidiaries which are Divis Laboratories (USA) Inc in USA and Divi’s Laboratories Europe AG in Switzerland; engaged in marketing/distribution of nutraceutical ingredients used in the food, beverage, dietary supplement, feed and pet food industries providing a greater reach to customers within these regions.
Business Segments
Generic APIs: Divi’s is a global leader in large-volume Generic APIs, offering a carefully selected portfolio of 30 commercially manufactured products, each produced in volumes ranging from 10s to 100s/1000s tons annually. This scale places Divi’s among the largest API manufacturers in the world.
Custom Synthesis: Design and development of synthesis routes for Active Pharmaceutical Ingredients (APIs), Advanced Intermediates and Regulatory Starting Materials (RSMs). Seamless process scale-up from kilo lab to commercial scale driven by a Quality by Design (QbD) approach. Proven expertise in complex chemistries, multi- step synthesis, green chemistry implementation through flow chemistry, biocatalysis, photochemistry, all underpinned by rigorous safety protocols.
Nutraceuticals: Divi’s Nutraceutical Facility, located at the Unit II manufacturing site, is an integrated setup for the production of active ingredients and finished forms of carotenoids. The facility includes a full-fledged R&D center, along with an Application Testing and Support Facility. Divi’s manufactures over 100 distinct forms of carotenoids and vitamins, supplying high-quality ingredients to leading food, dietary supplement, and animal feed manufacturers worldwide. Its product offerings are supported by complete backward integration, extensive experience in molecular synthesis, and localised technical support for international customers.
Products
Capecitabine
Carbidopa
Diltiazem HCl
Dextromethorphan Base
Dextromethorphan HBr
Fosphenytoin Sodium
Gabapentin
Iopamidol
Irbesartan
Levetiracetam
Levodopa
Mesalamine
Nabumetone
Naproxen
Naproxen Sodium
Niacin
Olmesartan Medoxomil
Phenylephrine HCl
Pregabalin
Proguanil HCl
Quetiapine Fumarate
Tamsulosin HCl
Telmisartan
Triprolidine HCl
Valacyclovir HCl
Valsartan
Venlafaxine HCl
Vigabatrin
Awards
- 2001: Occupational Health and Safety Management System (OHSAS-18001).
- 2002: May Day Award for Best Management.
- 2003: Shreshtha Suraksha Puraskar.
- 2003: Appreciation certificate for Meritorious performance in implementing the programmes of ‘Safe Guarding the Environment and Pollution Control’.
- 2003: Viswakarma Rashtriya Puraskar.
- 2004: Good Practice in Cleaner Production and Pollution Control.
- 2005: National Award for Excellence Water Management 2005.
- 2005: Appreciation certificate for Meritorious performance in implementing the programmes of ‘Safe Guarding the Environment and Pollution Control & Plantation work’.
- 2005: May Day Award for Best Management.
- 2006: National Award for Excellence Water Management and Certificate for Water efficient unit.
- 2006: National Award for Excellence Water Management and Certificate for Water efficient unit - Beyond the fence.
- 2006: Appreciation certificate for ‘Best Cleaner Production Practices and Waste Minimization Techniques’.
- 2007: Appreciation certificate for ‘Best Cleaner Production Practices and Waste Minimization Techniques’.
- 2008: Appreciation certificate for ‘Best Cleaner Production Practices and Waste Minimization Techniques’ on the Occasion of the World Environment
- 2009: Certified and Awarded for ‘Best Green Belt Development’.
- 2009: Occupational Health and Safety Management System (OHSAS-18001:2007).
- 2009: ISO 14001: 2004 (Re-Certification) ‘Environment Management System’.
- 2011: Best Green Belt Development.
- 2012: India Business Leader Award ‘First Generation Entrepreneur of the Year’.
- 2012: Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification).
- 2012: ISO 14001: 2004 (Re-Certification) ‘Environment Management System’.
- 2013: ISO 14064 - 1: 2006 Green House Gas Accounting verification.
- 2013: May Day award for Best Management.
- 2014: Winner of ‘Special Commendation’ for Golden Peacock Award for Corporate Social Responsibility.
- 2015: Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification).
- 2015: May Day award for Best Management.
- 2015: ISO 14001: 2004 (Re-Certification) ‘Environment Management System’.
- 2018: Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification).
- 2018: ISO 14001 : 2018 (Re- certification) ‘Environmental Management System’.
- 2018: May Day award for Best Management.
- 2021: CII-SR EHS Excellence Award 2020 – “4 Star Rating” for commitment to EHS practices.
- 2021: Best Corporate Social Responsibility Practices Award.
- 2021: Lifetime achievement Award for significant contribution in circular economy and waste management.
- 2021: Lifetime Achievement Award.
- 2022: EHS excellence Award.
- 2023: Best Management Award.
- 2023: Certificate of Appreciation for CSR Activities.
- 2023: Memento – Presented on the eve of “World Day for Safety and Health at Work”.
- 2024: Safety Suraksha Puraskar.
- 2024: Certificate of Appreciation – Recognition of OSH Achievement.
- 2025: Certificate of Appreciation in OSH Achievements.
- 2025: Excellence Awards for CSR Activities.
Milestones
1990: Inception of Divi’s as Divi’s Research Centre(DRC)
1995: Setup First Manufacturing facility(Unit-1) near Hyderabad
2000: First USFDA Inspection
2002: Commenced New Manufacturing Facility (Unit 2) near Vishakhapatnam
2003: Divi’s Labs listed on Indian Stock Exchange
2007: Set up Nutraceuticals facility at Unit 2
2008: First MFDS(Korea) inspection
2010: Established New Research Centre at Hyderabad
2011: First EU GMP and Japan PMDA Inspection
2012: First TGA Inspection
2013: First Slovenian Medicines Agency inspection for Unit-II
2014: Divi’s reaches a milestone of 8700 employees
2014: First COFEPRIS inspection
2015: New corporate office inaugurated at Hyderabad
2015: New Pilot block with 160 Reactors and Kilo Lab
2016: First Anvisa (Brazil) inspection
2017: Divi’s reaches a milestone of 11,000 employees and becomes one of the largest employers in the combined state of Telangana/Andhra Pradesh
2017: Reaches the milestone of being one among the top 3 API manufacturers in the world and one among the top API companies in Hyderabad
2018: Market capital of $5B Reached
2018: 10 new production blocks commissioned
2018: Expanded the product portfolio to over 30 products
2019: Setting up Manufacturing plant at Kakinada
2019: Additional investment of $250M towards expansion of production blocks in Unit -I and Unit- II
- 2020: Commissioning new production blocks in DC SEZ at Unit-I and DCV SEZ at Unit-II
- 2021: Groundbreaking of the Greenfield manufacturing facility (Unit 3) near Kakinada, Andhra Pradesh
- 2025: Commenced commercial operations of Phase I at Unit III, Kakinada
Comment